COVID-19 in the EU: Inpatient Treatment of Mild to Moderate COVID-19 in Patients Who Are Immunocompromised
In this episode, Drs. Witzenrath and Bartoletti share their approach to managing COVID-19 in people who are immunocompromised, including considerations for initial workup and treatment.
Decera Clinical Education Infectious Disease Podcast · Martin Witzenrath MD FERS, Michele Bartoletti MD PhD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including:
- Initial workup, which may include laboratory tests and/or imaging
- Latest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, including considerations for drug–drug interactions
Presenters:
Martin Witzenrath, MD, FERS
Medical Director
Charite Centrum 12
Internal Medicine & Dermatology
Professor and Chair for Respiratory Medicine and Critical Care
Department of Infectious Disease, Respiratory Medicine and Critical Care
Charite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin Franklin
Charite – University of Berlin
Berlin, Germany
Michele Bartoletti, MD, PhD
Associate Professor of Infectious Diseases
Department of Biomedical Sciences
Humanitas University
Pieve Emanuele (MI), Italy
Head of Infectious Diseases Unit
IRCCS Humanitas Research Hospital
Rozzano (MI), Italy
Link to full program:
https://bit.ly/4gu2gcU
Downloadable slides:
https://bit.ly/3CGlDBS
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.